Quality Control: Each batch of NF-kB GFP Reporter Vector (NK-GFP) is verified for plasmid DNA purity and sequence integrity by spectrophotometry and Sanger sequencing. Functional validation is performed by transient transfection in HEK293T cells followed by NF-kB pathway activation, using TNFα or PMA (TNFα 10 ng/mL or PMA 20 nM, 24h). Inducible GFP expression is confirmed by fluorescence microscopy (Figure 1).
Product Use: NK-GFP is for research use only and is not approved for human or animal use, or application in clinical or in vitro diagnostic procedures.
Shipping and Storage: The product is shipped at room temperature. Upon receipt, store at -20°C.
References: [1] Hayden, M. S., & Ghosh, S. (2024). NF-κB in biology and targeted therapy: new insights and perspectives. Signal Transduction and Targeted Therapy, 9, 27.
[2] Virchow, C., et al. (2025). NF-κB in inflammation and cancer. Cellular & Molecular Immunology, 22, 1310–1328.
[3] Chen, Y., et al. (2017). Development and characterization of a novel NF-κB reporter cell line. Journal of Neuroinflammation, 14, 145.